Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leandro Blas

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
World Journal of Urology|December 17, 2022
Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomyLeandro Blas, Masaki Shiota, Dai Takamatsu, et al.
Cancer Science|May 20, 2021
Long-term outcomes of androgen deprivation therapy in prostate cancer among Japanese men over 80 years oldLeandro Blas, Mizuki Onozawa, Masaki Shiota, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 21, 2023
NR5A2/HSD3B1 pathway promotes cellular resistance to second-generation antiandrogen darolutamideMasaki Shiota, Miho Ushijima, Shigehiro Tsukahara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 12, 2022
Impact of nerve sparing in robot-assisted radical prostatectomy on the risk of positive surgical margin and biochemical recurrenceHiroki Komori, Leandro Blas, Masaki Shiota, et al.
Asian Journal of Urology|February 1, 2023
Validation of user-friendly models predicting extracapsular extension in prostate cancer patientsLeandro Blas, Masaki Shiota, Shohei Nagakawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 20, 2023
Fusion-targeted biopsy significantly improves prostate cancer detection in biopsy-naïve menLeandro Blas, Masaki Shiota, Shigehiro Tsukahara, et al.
Prostate International|March 1, 2022
Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with castration-resistant prostate cancerSotaro Chikamatsu, Masaki Shiota, Shigetomo Yamada, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 22, 2021
Predictive factors of survival outcomes in first-line therapy for metastatic castration-resistant prostate cancerMasaki Shiota, Leandro Blas, Satoshi Kobayashi, et al.
Prostate International|May 5, 2022
Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancerShigetomo Yamada, Masaki Shiota, Leandro Blas, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 28, 2022
Effectiveness and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastases in real-world practice: A multi-institutional studyTakashi Matsumoto, Yoshifumi Hori, Masaki Shiota, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
World Journal of Urology|December 17, 2022
Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomyLeandro Blas, Masaki Shiota, Dai Takamatsu, et al.
Cancer Science|May 20, 2021
Long-term outcomes of androgen deprivation therapy in prostate cancer among Japanese men over 80 years oldLeandro Blas, Mizuki Onozawa, Masaki Shiota, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 21, 2023
NR5A2/HSD3B1 pathway promotes cellular resistance to second-generation antiandrogen darolutamideMasaki Shiota, Miho Ushijima, Shigehiro Tsukahara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 12, 2022
Impact of nerve sparing in robot-assisted radical prostatectomy on the risk of positive surgical margin and biochemical recurrenceHiroki Komori, Leandro Blas, Masaki Shiota, et al.
Asian Journal of Urology|February 1, 2023
Validation of user-friendly models predicting extracapsular extension in prostate cancer patientsLeandro Blas, Masaki Shiota, Shohei Nagakawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 20, 2023
Fusion-targeted biopsy significantly improves prostate cancer detection in biopsy-naïve menLeandro Blas, Masaki Shiota, Shigehiro Tsukahara, et al.
Prostate International|March 1, 2022
Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with castration-resistant prostate cancerSotaro Chikamatsu, Masaki Shiota, Shigetomo Yamada, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 22, 2021
Predictive factors of survival outcomes in first-line therapy for metastatic castration-resistant prostate cancerMasaki Shiota, Leandro Blas, Satoshi Kobayashi, et al.
Prostate International|May 5, 2022
Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancerShigetomo Yamada, Masaki Shiota, Leandro Blas, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 28, 2022
Effectiveness and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastases in real-world practice: A multi-institutional studyTakashi Matsumoto, Yoshifumi Hori, Masaki Shiota, et al.
Pageof 8